Journal de medecine vasculaire | 2019
[Conservative aneurysmorrhaphy for hemodialysis arteriovenous fistula].
The aim of this study was to evaluate the results of conservative surgical treatment of the aneurysmal complications of arteriovenous hemodialysis fistulae and to determine the factors predictive of long- and mid-term patency of treated fistulae. The surgical treatment was mainly based on caliber reduction and reconstruction.\n\n\nMETHODS\nThis was a descriptive retrospective study with a five-year duration, going from January 2013 to December 2018. This study included 40\xa0patients presenting aneurysmal complications of their hemodialysis vascular access who were treated with aneurysmorrhaphy.\n\n\nRESULTS\nThe mean age of the aneurysmal-complicated hemodialysis vascular access was 42\xa0months. The indications for treatment were puncture-related difficulties in 42.5% of cases, rapid increase of the aneurysmal diameter in 27.5%, skin thinning in 25% and aneurysmal rupture in 5%. The mean aneurysmal course was 6.6\xa0months with an average diameter of 3.25cm at the moment of management. The initial technical success rate was 100%. Twenty patients had complications in the postoperative period. Patency rates at 3, 6, 12 and 24\xa0months were 89.5%, 81.6%, 71% and 63.1%, respectively. Factors predictive of thrombosis were diabetes (P=0.001), peripheral arterial disease (P=0.003), number of punctures per week (P=0.003) and context of emergency presentation (P=0.001).\n\n\nCONCLUSION\nAneurysmorrhaphy seems to be the best conservative surgical treatment for aneurysmal complications of hemodialysis vascular access fistulae. This surgical approach allows us to conserve the native autologous vascular access and spare the patient s venous network.